The medical device sector must meet stringent regulatory requirements plus convince potential customers that they make reliable, safe products. Having a strong commitment to quality can help customers ...

The global medical device packaging market is expected to be grow from an estimated $12,409.8 million to $20,914 million in 2033, surging at a stable compound annual growth rate (CAGR) of 6.1% over ...

It seems as if 2024 is going to be a very busy year for Stryker in the M&A department. The Kalamazoo, MI-based company said it has completed the acquisition of Nico Corporation, a company focused on ...

Two years ago, FDA found itself scrambling to prevent shortages after shutdowns of two facilities that use ethylene oxide (also known as EtO, or EO) for medical device sterilization. The threat ...

Sign up for the QMED & MD+DI Daily newsletter.

Duane Morris Silicon Valley office partner Agatha H. Liu, PhD, practices intellectual property law, focusing on IP analysis, portfolio management, and strategic counseling. Drawing on more than 20 ...

Graphic accompanying Pedersen's POV, a weekly op-ed column by MD+DI Senior Editor Amanda Pedersen, for the medtech industry.

The world of physics has a foundation built on beautiful universal constants, things like π and ε 0, which work their way steadfastly into virtually every aspect of modern life. Ironically, universal ...

The medtech industry has made it through yet another challenging year of the pandemic. Still, there are many wins worth celebrating. Some of the technologies and trends we recognize as wins this year ...

The Medical Design Excellence Awards competition is the medical technology industry's premier awards program. Since 1998, the MDEAs have recognized achievements in medical product design and ...

St. Jude Medical announced Monday that it has exercised the option buy Spinal Modulation, a company in which it had previously invested $40 million. The Minnesota device maker is paying $175 million ...

On the pages of the calendar, it wasn’t too long ago that the thought of synthetic messenger RNA (mRNA) vaccines seemed quite imaginary to students in the Biotechnology Program at Thomas Jefferson ...